Migraine headache treatment Treximet, developed by pharmaceutical company Pozen (NASDAQ:POZN), has won a patent victory against generics companies looking to introduce their versions of the drug.A federal judge in Texas has ruled that two Treximet patents are valid and enforceable, and were infringed by Par Pharmaceutical (NYSE:PRX), Alphapharm and Dr. Reddy’s Laboratories (NYSE:RDY). A third [...]

GlaxoSmithKline‘s (NYSE:GSK) HIV treatment combivir will soon face its first competition from a generic drug.Teva Pharmaceutical Industries (NASDAQ:TEVA) has received U.S. Food and Drug Administration approval on its application to market a generic version of combivir. Combivir is a combination drug that pairs azidothymidine, also known as AZT, with another antiviral, lamivudine. The combination improved [...]

Among today’s current medical news: a former Nasdaq executive pleads guilty to insider trading that included pharma stocks; Johns Hopkins to use $10 million gift for patient safety center; Pfizer enters into strategic partnerships with CROs; and a study points to allergies as another way men and women are different.

MedCath (NASDAQ:MDTH) has sold another piece of its fragmenting hospital network — and its last remaining piece in North Carolina.New Hanover Regional Medical Center in Wilmington, North Carolina, has purchased MedCath’s ownership stake and management agreement in Coastal Carolina Heart for $5 million. Coastal Carolina Heart provides catheterization laboratory management services to the Wilmington Hospital.var [...]